Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1992 Aug;90(2):334-41.
doi: 10.1172/JCI115867.

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

Affiliations
Case Reports

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

M C Sneller et al. J Clin Invest. 1992 Aug.

Abstract

In mice, the two distinct autosomal recessive genes lpr and gld can induce a syndrome characterized by autoantibody formation and the progressive accumulation of an unusual CD4-CD8- T cell population in peripheral lymphoid tissue. This phenotype does not precisely mirror any human disease. In this report we describe two patients with a progressive lymphoproliferative disorder associated with autoimmunity. The peripheral blood and lymph nodes of these patients contained large numbers of an unusual CD4-CD8- T cell population. These CD4-CD8- T cells express surface markers characteristic of mature peripheral blood T cells (CD3, CD2, CD5), express the alpha/beta form of the T cell receptor, and do not express surface markers characteristic of immature thymocytes (CD1) or NK cells (CD16, CD56). Functionally, these cells exhibited deficient proliferation and lymphokine production upon stimulation with mitogenic antibodies to CD3 or CD2. Both proliferation and lymphokine production could be augmented by co-stimulation with an antibody directed at the CD28 determinant. The clinical and immunological features of this syndrome resemble the lymphoproliferative/autoimmune disease seen in lpr and gld mice.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1989 Mar 1;169(3):795-806 - PubMed
    1. Nature. 1989 Oct 5;341(6241):447-50 - PubMed
    1. FASEB J. 1987 Aug;1(2):103-9 - PubMed
    1. J Immunol. 1987 Mar 15;138(6):1660-6 - PubMed
    1. Nature. 1988 Jun 23;333(6175):742-6 - PubMed